Abstract:Recent evidence shows that resveratrol (RSV) may ameliorate high-glucose-induced cardiac oxidative stress, mitochondrial dysfunction and myocardial fibrosis in diabetes. However, the mechanisms by which RSV regulates mitochondrial function in diabetic cardiomyopathy have not been fully elucidated. Mitochondrial dysfunction contributes to cardiac dysfunction in diabetic patients, which is associated with dysregulation of peroxisome proliferator-activated receptor gamma coactivator-1α (PGC-1α). In this study we examined whether resveratrol alleviated cardiac dysfunction in diabetes by improving mitochondrial function via SIRT1-mediated PGC-1α deacetylation. T2DM was induced in rats by a high-fat diet combined with STZ injection. Diabetic rats were orally administered RSV (50 mg·kg –1 ·d –1 ) for 16 weeks. RSV administration significantly attenuated diabetes-induced cardiac dysfunction and hypertrophy evidenced by increasing ejection fraction (EF%), fraction shortening (FS%), ratio of early diastolic peak velocity (E velocity) and late diastolic peak velocity (A velocity) of the LV inflow (E/A ratio) and reducing expression levels of pro-hypertrophic markers ANP, BNP and β-MHC. Furthermore, manganese superoxide dismutase (SOD) activity, ATP content, mitochondrial DNA copy number, mitochondrial membrane potential and the expression of nuclear respiration factor (NRF) were all significantly increased in diabetic hearts by RSV administration, whereas the levels of malondialdehvde (MDA) and uncoupling protein 2 (UCP2) were significantly decreased. Moreover, RSV administration significantly activated SIRT1 expression and increased PGC-1α deacetylation. H9c2 cells cultured in a high glucose (HG, 30 mmol/L) condition were used for further analyzing the role of SIRT1/PGC-1α pathway in RSV regulation of mitochondrial function. RSV (20 μmol/L) caused similar beneficial effects in HG-treated H9c2 cells in vitro as in diabetic rats, but these protective effects were abolished by addition of a SIRT1 inhibitor sirtinol (25 μmol/L) or by SIRT1 siRNA transfection. In H9c2 cells, RSV-induced PGC-1α deacetylation was dependent on SIRT1, which was also abolished by a SIRT1 inhibitor and SIRT1 siRNA transfection. Our results demonstrate that resveratrol attenuates cardiac injury in diabetic rats through regulation of mitochondrial function, which is mediated partly through SIRT1 activation and increased PGC-1α deacetylation.

Resveratrol reversed rosiglitazone administration induced bone loss in rats with type 2 diabetes mellitus

Resveratrol Prevents Streptozotocin-Induced Diabetes by Inhibiting the Apoptosis of Pancreatic Β-Cell and the Cleavage of Poly (Adp-Ribose) Polymerase.

Effects of Rosiglitazone on Serum Levels of Lipids and Inflammatory Factors in Atherosclerotic Rats

Resveratrol Ameliorates Metabolic Disorders and Insulin Resistance in High-Fat Diet-Fed Mice.

Telmisartan alleviates rosiglitazone-induced bone loss in ovariectomized spontaneous hypertensive rats.

All-Trans Retinoic Acid Shifts Rosiglitazone-Induced Adipogenic Differentiation to Osteogenic Differentiation in Mouse Embryonic Fibroblasts

Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in aging C57BL/6 mice and in vitro studies

Resveratrol Prevents Ros-Induced Apoptosis In High Glucose-Treated Retinal Capillary Endothelial Cells Via The Activation Of Ampk/Sirt1/Pgc-1 Alpha Pathway

Effect of rosiglitazone on bone mineral density and bone microstructure in rats

Protective effects and the mechanism of Rosuvastatin on type 2 diabetic rats

Rosiglitazone Reduces Diabetes Angiopathy by Inhibiting Mitochondrial Dysfunction Dependent on Regulating HSP22 Expression

Resveratrol Attenuates Dapagliflozin-Induced Renal Gluconeogenesis Via Activating the PI3K/Akt Pathway and Suppressing the FoxO1 Pathway in Type 2 Diabetes.

Concurrently Using Rosiglitazone Prevents Glucosamine-Induced Islet Beta-Cell Apoptosis and Dysfunction.

Resveratrol Ameliorates Early Diabetic Nephropathy Associated with Suppression of Augmented TGF-β/smad and ERK1/2 Signaling in Streptozotocin-Induced Diabetic Rats.

Resveratrol facilitates bone formation in high-glucose conditions

Rosiglitazone improved advanced glycation end products-induced calcification in vitro by suppressing receptor for AGEs expression

Reduction of serum advanced glycosylation end products-peptides and monocyte chemoattractant protein-1 by rosiglitazone in type 2 diabetic rats

RESVERATROL ATTENUATES MYOCARDIAL ISCHEMIA/REPERFUSION INJURY VIA UPREGULATING ADIPONECTIN LEVEL AND MULTIMERISATION IN TYPE 2 DIABETIC MICE

Chondroitin Sulfate Prevents STZ Induced Diabetic Osteoporosis through Decreasing Blood Glucose, AntiOxidative Stress, Anti-Inflammation and OPG/RANKL Expression Regulation

Resveratrol ameliorates vasculopathy in STZ-induced diabetic rats: role of AGE-RAGE signalling.

Resveratrol Alleviates Diabetic Cardiomyopathy in Rats by Improving Mitochondrial Function Through PGC-1α Deacetylation